Publicacións en colaboración con investigadores/as de St. Michael's Hospital (18)

2023

  1. 2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry

    International Journal of Cardiology, Vol. 390

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Transcatheter aortic valve implantation in patients with extra-small aortic annuli

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 4, pp. e340-e351

2022

  1. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction

    European heart journal, Vol. 43, Núm. 7, pp. 641-650

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

  2. Safety and feasibility of mitraclip implantation in patients with acute mitral regurgitation after recent myocardial infarction and severe left ventricle dysfunction

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  3. Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 6, pp. 1259-1267

2020

  1. Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report

    Multiple Sclerosis and Related Disorders, Vol. 40

  2. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 12, pp. 1353-1362

  3. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430

  4. The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

    Multiple Sclerosis Journal, Vol. 26, Núm. 13, pp. 1658-1669

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

  2. Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis

    Neurology, Vol. 92, Núm. 13, pp. E1507-E1516

  3. Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

    Neurology, Vol. 92, Núm. 6, pp. 296-298

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

  2. Myasthenia gravis following alemtuzumab therapy for multiple sclerosis

    Neurology, Vol. 91, Núm. 13, pp. 622-624

  3. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

    Brain, Vol. 141, Núm. 4, pp. 1075-1084

2017

  1. Lesion topographies in multiple sclerosis diagnosis: A reappraisal

    Neurology, Vol. 89, Núm. 23, pp. 2351-2356